Viewing Study NCT05271292


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-01-08 @ 7:33 AM
Study NCT ID: NCT05271292
Status: RECRUITING
Last Update Posted: 2024-07-16
First Post: 2022-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Sponsor: Chipscreen Biosciences, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module